Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Leal TA"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-4 z 4
    Tytuł:
    Composição iônica majoritária de águas de chuva no centro da cidade de São Paulo
    Autorzy:
    Leal Tatiana F. M.
    Fontenele Anna P. G.
    Pedrotti Jairo J.
    Fornaro Adalgiza
    Pokaż więcej
    Temat:
    acid rain
    ionic composition
    air pollution
    Chemistry
    QD1-999
    Źródło:
    Química Nova, Vol 27, Iss 6, Pp 855-861 (2004)
    Opis pliku:
    electronic resource
    Relacje:
    http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422004000600003; https://doaj.org/toc/0100-4042; https://doaj.org/toc/1678-7064
    Dostęp URL:
    https://doaj.org/article/2762292ad6c940c1b0c4ac136da74691  Link otwiera się w nowym oknie
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    GC-MS Silylation Derivative Method to Characterise Black BIC Ballpoint 2-Phenoxyethanol Ratio Evaporation Profile-A Contribution to Ink Ageing Estimation.
    Autorzy:
    Leal TA; Forensic and Psychological Sciences Laboratory Egas Moniz, Campus Universitário-Quinta da Granja, Monte da Caparica, 2829-511 Caparica, Portugal.
    Ferreira C; Forensic and Psychological Sciences Laboratory Egas Moniz, Campus Universitário-Quinta da Granja, Monte da Caparica, 2829-511 Caparica, Portugal.; Molecular Pathology and Forensic Biochemistry Laboratory, Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), Instituto Universitário Egas Moniz (IUEM), Campus Universitário-Quinta da Granja, Monte da Caparica, 2829-511 Caparica, Portugal.
    Ribeiro A; Forensic and Psychological Sciences Laboratory Egas Moniz, Campus Universitário-Quinta da Granja, Monte da Caparica, 2829-511 Caparica, Portugal.
    Ahmad SM; Forensic and Psychological Sciences Laboratory Egas Moniz, Campus Universitário-Quinta da Granja, Monte da Caparica, 2829-511 Caparica, Portugal.; Molecular Pathology and Forensic Biochemistry Laboratory, Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), Instituto Universitário Egas Moniz (IUEM), Campus Universitário-Quinta da Granja, Monte da Caparica, 2829-511 Caparica, Portugal.
    Quintas A; Forensic and Psychological Sciences Laboratory Egas Moniz, Campus Universitário-Quinta da Granja, Monte da Caparica, 2829-511 Caparica, Portugal.; Molecular Pathology and Forensic Biochemistry Laboratory, Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), Instituto Universitário Egas Moniz (IUEM), Campus Universitário-Quinta da Granja, Monte da Caparica, 2829-511 Caparica, Portugal.
    Bernardo A; Forensic and Psychological Sciences Laboratory Egas Moniz, Campus Universitário-Quinta da Granja, Monte da Caparica, 2829-511 Caparica, Portugal.; Molecular Pathology and Forensic Biochemistry Laboratory, Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), Instituto Universitário Egas Moniz (IUEM), Campus Universitário-Quinta da Granja, Monte da Caparica, 2829-511 Caparica, Portugal.
    Pokaż więcej
    Źródło:
    Molecules (Basel, Switzerland) [Molecules] 2023 Jun 15; Vol. 28 (12). Date of Electronic Publication: 2023 Jun 15.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782).
    Autorzy:
    Leal TA; Winship Cancer Institute, Emory University, Georgia.
    Sharifi MN; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
    Chan N; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
    Wesolowski R; Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
    Turk AA; Indiana University Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.
    Bruce JY; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
    O'Regan RM; Department of Medicine, University of Rochester, Rochester, New York, USA.
    Eickhoff J; Department of Biostatistics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
    Barroilhet LM; Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
    Malhotra J; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
    Mehnert J; Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, New York City, USA.
    Girda E; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
    Wiley E; Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
    Schmitz N; School of Pharmacy, University of Wisconsin, Madison, Wisconsin, USA.
    Andrews S; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
    Liu G; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
    Wisinski KB; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
    Pokaż więcej
    Źródło:
    Cancer medicine [Cancer Med] 2022 Nov; Vol. 11 (21), pp. 3969-3981. Date of Electronic Publication: 2022 Apr 08.
    Typ publikacji:
    Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Neoplasms*/drug therapy
    Neoplasms*/pathology
    Paclitaxel*
    Humans ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carboplatin ; Poly(ADP-ribose) Polymerases
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial.
    Autorzy:
    Steffen McLouth LE; Department of Behavioral Science, Center for Health Equity Transformation, University of Kentucky College of Medicine, Lexington, KY, USA.
    Zhao F; Dana-Farber Cancer Institute & ECOG-ACRIN Biostatistics Center, Boston, MA, USA.
    Owonikoko TK; Emory University, Atlanta, GA, USA.
    Feliciano JL; Johns Hopkins University, Baltimore, MD, USA.
    Mohindra NA; Northwestern University, Chicago, IL, USA.
    Dahlberg SE; Dana-Farber Cancer Institute & ECOG-ACRIN Biostatistics Center, Boston, MA, USA.
    Wade JL 3rd; Heartland NCORP, Decatur, IL, USA.
    Srkalovic G; Sparrow Herbert-Herman Cancer Center, Lansing, MI, USA.
    Lash BW; Guthrie Clinic - Robert Packer Hospital, Sayre, USA.
    Leach JW; Metro Minnesota NCORP, Minneapolis, MN, USA.
    Leal TA; University of Wisconsin Carbone Cancer Center, Madison, WI, USA.
    Aggarwal C; University of Pennsylvania, Philadelphia, PA, USA.
    Cella D; Northwestern University, Chicago, IL, USA.
    Ramalingam SS; Emory University, Atlanta, GA, USA.
    Wagner LI; Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USA.
    Pokaż więcej
    Źródło:
    Cancer medicine [Cancer Med] 2020 Oct; Vol. 9 (20), pp. 7511-7523. Date of Electronic Publication: 2020 Aug 28.
    Typ publikacji:
    Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
    MeSH Terms:
    Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
    Lung Neoplasms/*drug therapy
    Lung Neoplasms/*pathology
    Small Cell Lung Carcinoma/*drug therapy
    Small Cell Lung Carcinoma/*pathology
    Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Benzimidazoles/administration & dosage ; Benzimidazoles/adverse effects ; Carboplatin/adverse effects ; Carboplatin/therapeutic use ; Etoposide/adverse effects ; Etoposide/therapeutic use ; Female ; Humans ; Lung Neoplasms/complications ; Lung Neoplasms/mortality ; Male ; Medication Adherence ; Middle Aged ; Patient Reported Outcome Measures ; Peripheral Nervous System Diseases/diagnosis ; Peripheral Nervous System Diseases/etiology ; Small Cell Lung Carcinoma/complications ; Small Cell Lung Carcinoma/mortality
    SCR Protocol:
    JET protocol
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-4 z 4

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies